Page last updated: 2024-10-25

chlorpropamide and Enterocolitis, Pseudomembranous

chlorpropamide has been researched along with Enterocolitis, Pseudomembranous in 1 studies

Chlorpropamide: A sulfonylurea hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. (From Martindale, The Extra Pharmacopoeia, 30th ed, p277)
chlorpropamide : An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is substituted by 4-chlorobenzenesulfonyl group and a hydrogen attached to the other nitrogen is substituted by propyl group. Chlorpropamide is a hypoglycaemic agent used in the treatment of type 2 (non-insulin-dependent) diabetes mellitus not responding to dietary modification.

Enterocolitis, Pseudomembranous: An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gupta, R1
Sachar, DB1

Other Studies

1 other study available for chlorpropamide and Enterocolitis, Pseudomembranous

ArticleYear
Chlorpropamide-induced cholestatic jaundice and pseudomembranous colitis.
    The American journal of gastroenterology, 1985, Volume: 80, Issue:5

    Topics: Chlorpropamide; Cholestasis; Enterocolitis, Pseudomembranous; Follow-Up Studies; Humans; Male; Middl

1985